IDRX-42
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IDRX-42, covering 2025-11-17 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy [Phase 3]